Annual ROE
-93.11%
-10.13%-12.21%
31 December 2023
Summary:
Predictive Oncology annual return on equity is currently -93.11%, with the most recent change of -10.13% (-12.21%) on 31 December 2023. During the last 3 years, it has risen by +280.03% (+75.05%). POAI annual ROE is now -116.34% below its all-time high of 569.68%, reached on 31 December 2008.POAI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-232.54%
-68.44%-41.71%
30 September 2024
Summary:
Predictive Oncology quarterly return on equity is currently -232.54%, with the most recent change of -68.44% (-41.71%) on 30 September 2024. Over the past year, it has dropped by -136.85% (-143.01%). POAI quarterly ROE is now -121.38% below its all-time high of 1087.51%, reached on 31 December 2015.POAI Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
POAI ROE Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -12.2% | -143.0% |
3 y3 years | +75.0% | -201.1% |
5 y5 years | +87.3% | -131.3% |
POAI ROE High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -12.2% | +75.0% | -419.6% | at low |
5 y | 5 years | -12.2% | +87.3% | -419.6% | +13.5% |
alltime | all time | -116.3% | +87.3% | -121.4% | +94.7% |
Predictive Oncology ROE History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -232.54%(+41.7%) |
June 2024 | - | -164.10%(+27.1%) |
Mar 2024 | - | -129.12%(+38.4%) |
Dec 2023 | -93.11%(+12.2%) | -93.29%(-2.5%) |
Sept 2023 | - | -95.69%(+17.0%) |
June 2023 | - | -81.76%(-10.8%) |
Mar 2023 | - | -91.69%(+15.7%) |
Dec 2022 | -82.98%(-9.4%) | -79.27%(+16.7%) |
Sept 2022 | - | -67.90%(+6.7%) |
June 2022 | - | -63.62%(+42.2%) |
Mar 2022 | - | -44.75%(-18.4%) |
Dec 2021 | -91.62%(-75.4%) | -54.81%(-29.0%) |
Sept 2021 | - | -77.23%(-26.6%) |
June 2021 | - | -105.21%(-39.6%) |
Mar 2021 | - | -174.16%(-35.2%) |
Dec 2020 | -373.14%(+8.6%) | -268.75%(+27.3%) |
Sept 2020 | - | -211.15%(+25.5%) |
June 2020 | - | -168.25%(+5.5%) |
Mar 2020 | - | -159.50%(-10.6%) |
Dec 2019 | -343.66%(-53.2%) | -178.35%(+77.4%) |
Sept 2019 | - | -100.56%(-25.5%) |
June 2019 | - | -135.07%(-72.7%) |
Mar 2019 | - | -495.39%(+41.0%) |
Dec 2018 | -734.79%(+121.3%) | -351.46%(+50.1%) |
Sept 2018 | - | -234.22%(+25.5%) |
June 2018 | - | -186.59%(+1.0%) |
Mar 2018 | - | -184.82%(-19.5%) |
Dec 2017 | -332.06%(+28.1%) | -229.48%(-14.9%) |
Sept 2017 | - | -269.75%(-15.4%) |
June 2017 | - | -318.67%(-7.8%) |
Mar 2017 | - | -345.59%(-11.4%) |
Dec 2016 | -259.15% | -390.10%(+28.4%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2016 | - | -303.89%(-46.8%) |
June 2016 | - | -571.68%(-87.0%) |
Mar 2016 | - | -4380.88%(-502.8%) |
Dec 2015 | -116.48%(-194.0%) | 1087.51%(+532.9%) |
Sept 2015 | - | 171.82%(+84.8%) |
June 2015 | - | 93.00%(-22.6%) |
Mar 2015 | - | 120.15%(-37.4%) |
Dec 2014 | 123.88%(-57.6%) | 192.07%(-13.5%) |
Sept 2014 | - | 221.98%(-45.5%) |
June 2014 | - | 407.51%(+9.3%) |
Mar 2014 | - | 372.69%(+6.6%) |
Dec 2013 | 292.26%(+30.1%) | 349.56%(+5.7%) |
Sept 2013 | - | 330.72%(+25.0%) |
June 2013 | - | 264.57%(-20.1%) |
Mar 2013 | - | 331.06%(+19.9%) |
Dec 2012 | 224.70%(+35.4%) | 276.09%(-19.2%) |
Sept 2012 | - | 341.67%(+37.3%) |
June 2012 | - | 248.91%(+39.3%) |
Mar 2012 | - | 178.74%(-1.9%) |
Dec 2011 | 165.98%(+168.7%) | 182.17%(+122.0%) |
Sept 2011 | - | 82.06%(+28.8%) |
June 2011 | - | 63.72%(+25.3%) |
Mar 2011 | - | 50.85%(-17.9%) |
Dec 2010 | 61.78%(-50.0%) | 61.94%(+3.3%) |
Sept 2010 | - | 59.99%(-29.8%) |
June 2010 | - | 85.45%(-23.2%) |
Mar 2010 | - | 111.32%(-11.1%) |
Dec 2009 | 123.49%(-78.3%) | 125.15%(-51.2%) |
Sept 2009 | - | 256.62%(-73.5%) |
June 2009 | - | 968.75%(+32.6%) |
Mar 2009 | - | 730.54%(+80.1%) |
Dec 2008 | 569.68% | 405.56% |
FAQ
- What is Predictive Oncology annual return on equity?
- What is the all time high annual ROE for Predictive Oncology?
- What is Predictive Oncology annual ROE year-on-year change?
- What is Predictive Oncology quarterly return on equity?
- What is the all time high quarterly ROE for Predictive Oncology?
- What is Predictive Oncology quarterly ROE year-on-year change?
What is Predictive Oncology annual return on equity?
The current annual ROE of POAI is -93.11%
What is the all time high annual ROE for Predictive Oncology?
Predictive Oncology all-time high annual return on equity is 569.68%
What is Predictive Oncology annual ROE year-on-year change?
Over the past year, POAI annual return on equity has changed by -10.13% (-12.21%)
What is Predictive Oncology quarterly return on equity?
The current quarterly ROE of POAI is -232.54%
What is the all time high quarterly ROE for Predictive Oncology?
Predictive Oncology all-time high quarterly return on equity is 1087.51%
What is Predictive Oncology quarterly ROE year-on-year change?
Over the past year, POAI quarterly return on equity has changed by -136.85% (-143.01%)